Progression to late AMD (neovascular AMD, geographic atrophy or both) · people with AMD
Lutein with or without zeaxanthin showed no clear difference in progression to late AMD (neovascular AMD, geographic atrophy, or both) compared with placebo (low certainty).
1 finding from 1 review
Progression to neovascular AMD · people with AMD
Lutein with or without zeaxanthin showed no clear difference in progression to neovascular AMD compared with placebo (low certainty).
1 finding from 1 review
Total hip BMD · premenopausal women (age 18−47.3 years)
1 finding from 1 review
Lumbar spine bone mineral density (BMD) · premenopausal women (age 18−47.3 years)
1 finding from 1 review
Quality of life · premenopausal women (age 18−47.3 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vertebral fracture · premenopausal women (age 18−47.3 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Non‐vertebral fractures · premenopausal women (age 18−47.3 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Acceptability: total withdrawals · premenopausal women (age 18−47.3 years)
Calcium showed no clear difference in withdrawals from the study for any reason compared with placebo (moderate certainty).
1 finding from 1 review
Serious adverse events · premenopausal women (age 18−47.3 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
QoL: CFQ‐R · people with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
QoL: CFQoL · people with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · people with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
PIVKA II levels: change in PIVKA II (ng/mL) · people with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Uncarboxylated osteocalcin: change in carboxylation of osteocalcin level (% Glu‐OC) · people with cystic fibrosis
1 finding from 1 review
Intervention not reported
Time to cessation of bleeding · people with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Bone mineral density: lumbar spine z score · people with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Healing of rickets (number) Definition: normal alkaline phosphatase and bone radiograph
The intervention may leads to higher healing of rickets (number) Definition: normal alkaline phosphatase… (low certainty).
1 finding from 1 review
Intervention not reported
Morbidity (number) Definition: fractures
It is very uncertain whether the intervention changes morbidity (number) Definition: fractures (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events (number)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found